+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Europe Insulin Delivery Devices Market Outlook, 2028 - Product Thumbnail Image

Europe Insulin Delivery Devices Market Outlook, 2028

  • Report
  • November 2023
  • 122 Pages
  • Europe
From
North America Insulin Delivery Devices Market Outlook, 2028 - Product Thumbnail Image

North America Insulin Delivery Devices Market Outlook, 2028

  • Report
  • November 2023
  • 119 Pages
  • North America
From
Diabetes Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Diabetes Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 190 Pages
  • Global
From
Type 2 Diabetes Medications Market - Global Forecast 2025-2030 - Product Thumbnail Image

Type 2 Diabetes Medications Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 180 Pages
  • Global
From
From
Hypoprothrombinemia Treatment Market - Global Forecast to 2030 - Product Thumbnail Image

Hypoprothrombinemia Treatment Market - Global Forecast to 2030

  • Report
  • August 2025
  • 187 Pages
  • Global
From
Biosimilar Growth Hormones Market Report 2025 - Product Thumbnail Image

Biosimilar Growth Hormones Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
5-Alpha Reductase Deficiency Market Report 2025 - Product Thumbnail Image

5-Alpha Reductase Deficiency Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
Loading Indicator